Pharma Alert Q&A: Viread China’s First Victim of Compulsory Licensing?

Innovative pharmaceuticals take notice. Reuters’ Tan Ee Lyn asserts that China “overhauled parts of its intellectual property laws” to allow generics companies to start exploiting patented medicines cheaply. In other words allowing compulsory licensing. Tan mentioned one medicine for HIV patients as a possible candidate for compulsory licensing.



China is known to be looking at Gilead Sciences Inc’s tenofovir, which is recommended by the World Health Organisation as part of a first-line cocktail treatment for AIDS patients, two
continue reading…

Sino-U.S. Investment Vehicle To Bring U.S. Medicines Into Chinese Pharmaceutical Market

In the U.S. the pharmaceutical industry has proprietary technology, but China has enough financial resources and a huge domestic market. Therefore an opportunity presents itself for those who can bridge these two markets. Michelle Jarboe McFee has an interesting article about a partnership between Newsummit Pharmaceutical Group, a biomedical company in Shanghai and Cleveland Bio […]

How To Cure The Distribution Channel of Pharmaceuticals Which Includes Counterfeit Products

Business Research Yearbook, (chief editor Margaret Goralski) 2011 is out. The subtitle is “Balancing Profitability and Sustainability: Shaping the Future of Business”. It includes “Problems of Counterfeit International Pharmaceutical Products” by Branko Cavarkapa (Eastern Connecticut State University) and Michael G. Harvey (University of Mississippi & Bond University Australia). I don’t understand really why it is located in Chapter 7 […]

Why China Is Preferred Over India By The U.S. Pharmaceutical Industry

10 articles to go: IP Dragon on its way to its 1000th article Joseph Alexander wrote for that the Pharmaceutical Research and Manufacturers of Amercia (PhRMA) choose for the China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA) to cooperate and continue a regular dialogue. Why PhRMA did not choose to sign a cooperation agreement […]

Fake Medicines Advertised on Taiwanese TV, Radio and in Newspapers

Taiwan’s Health Minister Yang Chih-liang warns that the public should not believe TV, radio and newspaper advertisments selling fake pharmaceuticals. Minister Yang called the proliferation of counterfeit drugs more serious than drug trafficking. Read the China Post article here.

Incremental Pharmaceutical Inventions in China and India: “No Need to Reinvent the Wheel”

For those who missed it, in 2008, the Intellectual Property Association of Japan (IPAJ) published an interesting article by Parama Sinha Palit and Bhaskar Bhattacharya called ‘Does Intellectual Property Laws in India and China Encourage Innovation’. Messrs Palit and Bhattacharya, both senior associate with Corporate Law Group are advocates of the patentability of incremental, cumulative […]

“Eli Lilly Lobbies on Counterfeiting And Regulatory Issues Involving China”

Eli Lilly, a US drugmaker, lobbied for 3.3 million dollar in the third quarter of 2008 on issues, which include counterfeiting problems and regulatory reform in China, according to the Associated Press. Read the AP article via the site of Forbes here.